Polymeric Nanoscale Drug Carriers Mediate the Delivery of Methotrexate for Developing Therapeutic Interventions Against Cancer and Rheumatoid Arthritis

Methotrexate (MTX) is widely used as an anticancer and anti-inflammtory drug for treating various types of cancer and autoimmune diseases. The optimal dose of MTX is known to inhibit the dihydrofolatereductase that hinders the replication of purines. The nanobiomedicine has been extensively explored...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Wen-Jun, Huang, Dong-Xu, Liu, Shuang, Sha, Ying-Li, Gao, Feng-hui, Liu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526065/
https://www.ncbi.nlm.nih.gov/pubmed/33042817
http://dx.doi.org/10.3389/fonc.2020.01734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526065/
https://www.ncbi.nlm.nih.gov/pubmed/33042817
http://dx.doi.org/10.3389/fonc.2020.01734

Ejemplares similares